Not All GDUFA II Facility Deficiencies Require Major Amendments, FDA Decrees
Executive Summary
Final guidance clarifies US FDA’s position on what is considered a major amendment subject to longer reviews, and what is considered a minor amendment subject to shorter reviews under GDUFA II.